[A study of 5-ASA use among young patients with Crohn disease. Regular drug revision is of significance for all children with chronic disease].
Hedin
A
A
Apoteket Danderyds sjukhus, Stockholm. annika.hedin@apoteket.se
Ehrsson
H
H
Eksborg
S
S
Finkel
Y
Y
Hildebrand
H
H
Lidehäll
A K
AK
D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001835:Body Weight; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000008:administration & dosage*; D012189:Retrospective Studies; D012460:Sulfasalazine / Q000008:administration & dosage*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D019804:Mesalamine